网络出版日期: 2016-02-18
基金资助
科技部国际科技合作项目(2011DFA32190)资助
Development of human embryonic stem cell platforms for human health-safety #br# evaluation
Online published: 2016-02-18
Supported by
Supported by the International Scientific and Technical Cooperation Pragram of China (2011DFA32190)
俞光岩 , 曹彤 , 邹晓晖 , 张学慧 , 傅歆 , 彭双清 , 邓旭亮 , 李盛林 , 刘鹤 , 肖苒 , 欧阳宏伟 , 彭晖 , 陈晓 , 赵增明 , 王晓颖…… . 基于人胚胎干细胞健康安全评价体系的构建[J]. 北京大学学报(医学版), 2016 , 48(1) : 1 -4 . DOI: 10.3969/j.issn.1671-167X.2016.01.001
The human embryonic stem cells (hESCs) serve as a self-renewable, genetically-healthy, pluripotent and single source of all body cells, tissues and organs. Therefore, it is considered as the good standard for all human stem cells by US, Europe and international authorities. In this study, the standard and healthy human mesenchymal progenitors, ligament tissues, cardiomyocytes, keratinocytes, primary neurons, fibroblasts, and salivary serous cells were differentiated from hESCs. The human cellular health-safety of NaF, retinoic acid, 5-fluorouracil, dexamethasone, penicillin G, adriamycin, lead acetate PbAc, bisphenol A-biglycidyl methacrylate (Bis-GMA) were evaluated selectively on the standar-dized platforms of hESCs, hESCs-derived cardiomyocytes, keratinocytes, primary neurons, and fibroblasts. The evaluations were compared with those on the currently most adopted cellular platforms. Parti-cularly, the sensitivity difference of PM2.5 toxicity on standardized and healthy hESCs derived fibroblasts, currently adopted immortalized human bronchial epithelial cells Beas-2B and human umbilical vein endothelial cells (HUVECs) were evaluated. The results showed that the standardized hESCs cellular platforms provided more sensitivity and accuracy for human cellular health-safety evaluation.
Key words: Embryonic stem cells; Toxicity tests; Cell differentiation; In vitro; Humans
/
| 〈 |
|
〉 |